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Background:  We  present  the clinicopathological  characteristics  of lupus  nephritis  (LN)  in a
subset  of  population  from  Western  Saudi  Arabia.
Materials and  methods:  We  retrospectively  analysed  previously  diagnosed  148  renal
biopsies  in  cases  with  systemic  lupus  erythematosus  (SLE)  from  two  medical  centres.  Micro-
scopic slides  from  these  patients  were retrieved  and  re-assessed  according  to  the  WHO
and ISN/RPS  classiﬁcations  by histological,  immunological  and  electron  microscopic  items.
Clinical and laboratory  ﬁndings  were  retrieved  from  patients’  medical  records.
Results: Median  age  of  patients  years  is 24 (range:  2–65),  females  (85.1%),  and  males  (14.9%).
The frequency  of cases  in  each  class  according  to  WHO  classiﬁcation  and  ISN/RPS  classiﬁ-
cation  was  nearly  the  same  and  was  as  follows:  class  I  (0%),  class  II (12.8%),  class III (8.8%),
class  IV  (51.4%),  class  V (23%),  and  class  VI (4%).  For  IV class,  IV-G  (41.9%)  subcategory  was
higher than  IV-S  (9.4%).  Immunoﬂuorescence  examination  revealed  positive  staining  for
IgG and  C3  in  98.4%  and  97.6%  of  cases  respectively.  In conclusion,  class  IV (51.4%)  is  the
predominant  class,  followed  by class  V  (23%).
Conclusion: There  are  differences  in  clinicopathological  data reported  from  this  study  with
other studies.  Continuous  reporting  from  different  national  specialised  nephrology  centres
is recommended  for  better  elucidation  of  the  natural  history  of  lupus  nephritis  in  Saudi
patients.
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1. Introduction
Systemic lupus erythematosus (SLE) is a chronic dis-
ease  with autoimmune pathogenesis and manifests as low
grade  inﬂammation and may  advance to multiorgan fatal
damage  [1]. In SLE patients who have abnormal urine
and/or reduced renal function, renal biopsy is performed
to  provide prognostic data and direct the initial therapeu-
tic  approach [2]. The incidence of lupus nephritis (LN) in
SLE  is divergent around the world and may  be related to
different  ethnic and genetic background [3–5].
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Most patients with LN have an immune complex-
ediated glomerular disease, often associated with tubu-
ointerstitial changes with or without immune deposits.
nvolvement of the renal vasculature is also common,
anging from indolent vascular immune deposits to ﬁbri-
oid  necrosis and thrombotic microangiopathy [6]. Renal
nvolvement is reﬂected by different clinical and laboratory
anifestations which vary considerably around different
eographic distribution [5].
Currently, renal histological changes are identi-
ed according the International Society of Nephrology
ISN)/Renal Pathology Society (RPS) Classiﬁcation of LN
7]  which is entirely based on glomerular changes. It
as  designed to eliminate ambiguities and standardise
eﬁnitions. Major changes from 1995 modiﬁed WHO
lassiﬁcation [8] include better standardisation of renal
iopsies in lupus patients [7] and separation of segmental
nd global lesions [9] which was suggested by a study in
000  [10] who concluded that cases with diffuse prolifera-
ive  LN and segmental lesions have poorer prognosis than
hose  with global diffuse proliferative.
We aim in this study to evaluate the pathological and
linical characteristics of a subset of LN cases from two
edical centres in the Western region of Saudi Arabia and
ompare  these ﬁndings with ﬁndings from other regions in
audi  Arabia, near-by countries, and international ﬁgures.
.  Materials and methods
The  study group comprised a total of 148 biopsies
iagnosed as lupus nephritis from two large tertiary med-
cal  centres in Jeddah (Western region of Saudi Arabia);
ing Abdulaziz University Hospital (period from 1995 to
011)  and King Faisal Specialist Hospital and Research
entre (2000–2011). Patients’ histological materials were
etrieved from the archive of department of Pathology
n the above mentioned centres. The microscopic criteria
escribed in LN, and the deﬁnition of terms, were collected
rom the literature. The renal biopsy specimens were stud-
ed  by light microscopy, immunoﬂuorescence, and electron
icroscopy. Haematoxylin and Eosin (H&E), Periodic Acid-
chiff  (PAS), Masson Trichrome and Jones Methenamine
liver (JMS) stained slides of cases were re-examined to
etrieve  data according the standards of deﬁning diagnostic
erms reported elsewhere [11].
The activity and chronicity indices (AI and CI) were
etrieved if were reported whenever possible and re-
eported for cases that were not reported using the
emi-quantitative scoring schema developed by Austin
t  al. [12]. Each activity and chronicity factor is graded on
able 1
istribution of immunoﬂuorescence ﬁndings.
Negative Trace 1+ 
IgG 2 (1.6%) 0 (0%) 10 (8%)
IgA 18 (14.7%) 4 (3.3%) 34 (27.
IgM 11 (8.9%) 1 (0.8%) 43 (34.
C3  3 (2.4%) 0 (0%) 16 (12.
C4  24 (32.9%) 13 (17.8%) 28 (38.
C1q 12 (12%) 0 (0%) 22 (22%
Fibrinogen 16 (64%) 1 (4%) 4 (16%d Ultrastructure 2 (2014) 12–19 13
a  scale of 0, 1, 2, and 3 depending on the percentage of
involvement of all viable glomeruli (AI) and on all glomeruli
(CI)  present in sections; where 0 (absence of lesions), 1
(lesions  involving up to 25%), 2 (lesions involving 25–50%),
and  3 (lesions involving >50%). The activity items cellular
crescents and necrosis are weighed by a factor of x2.
Results of immunoﬂuorescence for immunoglobulin
G (IgG), immunoglobulin A (IgA), immunoglobulin M
(IgM),  C3, C4, C1q and ﬁbrinogen deposits were semi-
quantitatively graded from 0 to 4 according to the intensity
of  ﬂuorescence. The immunoﬂuorescence ﬁndings of each
patient  were collected and analysed. Electron microscopy
reports were used whenever needed for subendothelial,
subepithelial, mesangial and intramembranous electron
dense deposits. Renal involvement was assessed and
cases  were reclassiﬁed using both the modiﬁed WHO  and
ISN/RPS  classiﬁcations {wherever were not used}. For cat-
egorisation of classes III and IV of ISN/RPS classiﬁcation,
active lesions were considered according to the presence of
cellular  crescents, ﬁbrinoid necrosis, and a chronic lesion
when  glomerular sclerosis, and interstitial ﬁbrosis are
present [7].
Patients’ clinical data were collected from the med-
ical archives of departments of Internal medicine. The
clinical ﬁndings were analysed as patients’ age, sex,
nationality, the presence of hypertension, diabetes, renal
dialysis  before and after renal biopsy, renal impairment
before renal biopsy, and nephrotic syndrome. Labora-
tory results were also analysed including; haemoglobin,
erythrocyte sedimentation rate ESR, serum C3, C4, anti-
nuclear antibodies (ANA), anti-DNA, CRP, anti-cardiolipin
IgM, anti-cardiolipin IgG, urine protein, urine RBC, Urine
cast,  and 24 h protein were also retrieved. Revision of
therapies applied were also collected; hydroxychloro-
quine (Plaquenil®) azathioprine, cyclophosphamide, pulse
steroid  prednisone, mycophenolate mofetil (CellCept®),
methotrexate, cyclosporine. Patient mortality records were
collected.
The  work in this study was  in accordance with the ethics
committee of Faculty of Medicine, King Abdulaziz Univer-
sity,  Saudi Arabia, and according to the ethical guidelines
of the 1975 Declaration of Helsinki. Statistical analysis was
done  in the Statistical Package for Social Sciences (SPSS®)
version  16. Frequencies and results were presented as
median (range).3.  Results
Median age of patients is 24 years and range is (2–65).
Females constitute 126 (85.1%) and males 22 (14.9%) with
2+ 3+ 4+
 35 (28%) 71 (56.8%) 7 (5.6%)
9%) 46 (37.7%) 20 (16.4%) 0 (0%)
7%) 51 (41.1%) 18 (14.5%) 0 (0%)
9%) 38 (30.7%) 62 (50%) 5 (4%)
3%) 7 (9.6%) 1 (1.4%) 0 (0%)
) 40 (40%) 24 (24%) 2 (2%)
) 3 (12%) 1 (4%) 0 (0%)
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Table  2
Distribution of cases falling in each class in modiﬁed WHO  classiﬁcation (1995).
Class Brief description Number (%) Age (median
{range})
Sex
F M
I (normal glomeruli)
I-A  Normal glomeruli by all techniques 0 0 0 0
I-B  Normal glomeruli by light microscopy
but deposits are present
0 0 0 0
II  (mesangial LN)
II-A Mesangial widening and/or mild
hypercellularity (+)
15 (10.1%) 25  {16–41} 14  1
II-B  Mesangial widening and/or moderate
hypercellularity (++)
4 (2.7%) 21 {19–26} 4 0
III  (focal and segmental
proliferative LN)
III-A  Active necrotising lesions 0 0 0 0
III-B  Active and sclerosing lesions 5 (3.4%) 21 {11–29} 3 2
III-C  Sclerosing lesions 8 (5.4%) 33.5 {16–44} 4 4
IV  (diffuse proliferative
LN)
IV-A  With segmental lesions 9 (6.1%) 20 {9–65} 7 2
IV-B  With active necrotising lesions 41 (27.7%) 26 {2–60} 36 5
IV-C  With segmental and sclerosing lesions 14 (9.4%) 19.5 {3–44} 13 1
IV-D  With sclerosing lesions 12 (8.2%) 27.5 {16–44} 11 1
V  (diffuse membranous
LN)
V-A  Pure membranous 29 (19.6%) 23 {7–50} 25 4
V-B  Associated with lesions of class II (A or 5  (3.4%) 22 {10–52{ 3 2B)
VI  Advanced sclerosing LN 
female to male ratio 5:1. In the patient’s population, 97
(65.5%)  of them were Saudi and 51 (34.5%) were non-Saudi.
3.1.  Pathological features
The  mean and standard deviation (SD) of activity and
chronicity indices are 7.2454 (4.6993) and 3.0629 (2.3088)
respectively. In a range between 15.5% and 83.1% of cases
immunoﬂuorescence results could not be reported in this
study.  Reasons are; no tissue available, sclerosed glomeruli,
Table 3
Distribution of cases falling in each class in ISN/RPS classiﬁcation (2003).
Class Brief description 
I (minimal mesangial LN) Normal glomeruli by light microscopy b
immune deposits by immunoﬂuorescen
II  (mesangial proliferative LN) Purely mesangial hypercellularity of an
mesangial matrix expansion by light m
mesangial  immune deposits
III  (focal LN)
III (A) Active lesions 
III (A/C) Active and chronic lesions 
III (C) Chronic inactive lesions
IV  (diffuse LN)
IV-S (A) Active: diffuse segmental proliferative L
IV-G (A) Active: diffuse global proliferative LN 
IV-S (A/C) Active and chronic: diffuse segmental p
sclerosing  LN
IV-G (A/C) Active and chronic: diffuse global prolif
sclerosing LN
IV-S (C) Chronic inactive: diffuse segmental scle
IV-G (C) Chronic inactive: diffuse global sclerosi
V  (membranous LN) Global or segmental subepithelial immu
with or without mesangial alterations. 
without co-existing class III or IV LN
VI  (advanced sclerosis LN) ≥90% of glomeruli are globally sclerose
residual activity6 (4%) 23 {7–31} 6 0
missing surgical pathology report, not done, no glomeruli
in  sections, or patients presented to these centres with
parafﬁn embedded blocks for referral. IgG and IgA showed
positivity in 98.4% and 82% of cases respectively. IgM
showed positivity in 90.3%. C3 and C4 showed positivity
in  97.6% and 49.3% respectively. C1q was  positive in 88%
of  cases. Fibrinogen was  positive in 32% of cases done
(Table 1).
The  frequency of cases in each class within the
WHO  classiﬁcation and ISN/RPS classiﬁcation is shown in
Number (%) Age (median
{range})
Sex
F M
ut mesangial
ce
0  0 0 0
y degree OR
icroscopy with
19  (12.85%) 22 {16–41} 18 1
0 0 0 0
5 (3.4%) 21 {11.5–29} 3 2
8  (5.4%) 33.5 {16–44} 4 4
N 3 (2.05%) 25 {11–28} 2 1
13 (8.8%) 23 {16–40} 13 0
roliferative and 6 (4.05%) 22 {14–60} 6 0
erative and 33 (22.3%) 27 {2–53} 28 5
rosing LN 5 (3.4%) 16 {9–20} 3 2
ng LN 16 (10.8%) 27.5 {15–65} 15 1
ne deposits
With or
34 (22.9%) 22.5 {7–52} 28 6
d without 6 (4.05%) 23 {7–31} 6 0
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in  18.7% of cases renal dialysis was performed after renal
biopsy. Mortality rate represent 3.2% of the study group.
The  cause of death was  not reported. Data is shown in
Table  4.
Table 4
Distribution of clinical ﬁndings.
Finding Present (yes) Absent (no)
Diabetes mellitus 8 (6.1%) 124 (93.9%)
Hypertension 88 (62.9%) 52 (37.1%)ig. 1. (A) Lupus class II (mesangial proliferative lupus nephritis). A glome
upus  nephritis). A glomerulus shows segmental endocapillary hypercellu
nd  (D) Lupus class IV (diffuse lupus nephritis) G-AC. Global severe endo- 
xpansion  with hypercellularity (C stained with H&E) and (D stained with
ables 4 and 5. The frequency of each class is as follows:
one of cases classiﬁed as class I. Within WHO  classiﬁca-
ion; class II (12.8%), class III (8.8%), class IV (51.4%), class
 (23%), and class VI (4%). While within ISN/RPS classiﬁ-
ation; class II (12.85%), class III (8.8%), class IV (51.3%),
lass V (22.9%), and class VI (4%). Subcategories falling in
lass  III in both classiﬁcations were the same. For class
V  in WHO  classiﬁcation (Table 2), active lesions (IV-B)
ere  the highest among other subclasses (27.7%) while seg-
ental  lesions were the lowest (6.1%). In class IV within
SN/RPS (Table 5), global lesions were higher (41.9%) than
egmental lesions (9.4%). In segmental lesions; there is no
ifference  between subcategories {IV-S (A), (C) and (A/C)},
hile  in global lesions the active and chronic lesions were
he  highest (22.3%) among other subcategories. Figs. 1–3
epresent histological, immunoﬂuorescence, and electron
icroscope ﬁndings in selected cases..2. Clinical ﬁndings
Out  of 148 cases retrieved, a range of 5.4–48.65% of cases
here were partially missing clinical and laboratory dataows mild mesangial hypercellularity (H&E) 200×. (B) Lupus class III (focal
esangial hypercellularity, and capillary wall thickening (JMS) 200×. (C)
acapillary proliferation, wireloop lesions, leucocyte inﬂux and mesangial
00×.
(Table  3). The range of duration of lupus nephritis is 6–408
months while the median is 84 months. In this study, 8
(6.1%)  of patients were diabetic, 88 (62.9%) patients were
hypertensive, 76 (58.5%) patients had nephrotic syndrome,
and  47 (34.8%) had renal impairment prior to renal biopsy.
Patients were subjected to renal dialysis for impaired renal
function  in 6.1% of cases before taking renal biopsy. WhileNephrotic syndrome 76 (58.5%) 54 (41.5%)
Renal impairment before biopsy 47 (34.8%) 88 (65.2%)
Dialysis before biopsy 8 (6.1%) 123 (93.9%)
Dialysis after biopsy 26 (18.7%) 113 (81.3%)
Mortality 4 (3.2%) 120 (96.8%)
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Fig. 2. (A) and (B) Lupus class IV S-A. A glomerulus shows diffuse segmental proliferative and sclerosing lupus nephritis (A stained with H&E) and (B stained
l subepi
omerulawith  JMS) 200×. (C) Lupus class V (membranous lupus nephritis). Globa
(advanced  sclerotic lupus nephritis). A glomerulus with diffuse, global gl
200×.
3.3. Laboratory ﬁndingsTable  5 shows all the laboratory abnormalities in our
patients. Anti-nuclear antibody and anti-DNA antibody
were positive in 95.7% of tested patients. Elevated ESR and
CRP  were found in 77 (82.8%) and 59 (74.7%) of tested
Table 5
Distribution of laboratory ﬁndings.
Laboratory test Positive Normal
ANA 112 (95.7%) 5 (4.3%)
Anti-DNA  112 (95.7%) 5 (4.3%)
ESR  77 (82.8%) 16 (17.2%)
CRP  59 (74.7%) 20 (25.3%)
C3  22 (19.5%) 91 (80.5%)
C4  15 (13.3%) 98 (86.7%)
ACL  IgM 10 (13.2%) 66 (86.8%)
ACL  IgG 20 (26.3%) 56 (73.7%)
Urine  protein 75 (77.3%) 22 (22.7%)
Urine  RBC 101 (88.6%) 13 (11.4%)
Urine  cast 58 (63%) 34 (37%)
24  h protein 105 (89.7%) 12 (10.3%)thelial and subepithelial spike formation (JMS) 200×. (D) Lupus class VI
r sclerosis with interstitial mononuclear inﬂammatory inﬁltrates (H&E)
patients respectively. Complements C3 and C4 were low
in  91 (80.5%) and 98 (86.7%) of tested patients respectively.
Anti-cardiolipins IgM and IgG showed elevated levels in
13.2%  and 26.3% of tested cases respectively. Proteinuria
and urinary cast was reported in 75 (77.3%) and in 58
(63%) of patients. While 24 h protein showed positivity in
105  (89.7%) tested cases. Haematuria was  reported in 101
(88.6%)  patients.
3.4.  Treatments
Frequency of drugs administered is shown in Table 6.
73.3%  of patients were treated with Plaquenil®. CellCept®
was  the second most frequently administered drug. Aza-
thioprine and cyclophosphamide were administered in
equal  percentage of patients.4.  Discussion
There is a large literature regarding the clinicopatholog-
ical criteria of LN. However, these ﬁndings are still reported
W.  Gomaa et al. / Journal of Microscopy and Ultrastructure 2 (2014) 12–19 17
Fig. 3. (A) Immunoﬂuorescence for IgG shows positive staining in a case of lupus nephritis (arrow). (B) Immunoﬂuorescence for c3 shows positive staining
i hritis re
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Fn  a case of lupus nephritis (arrow). (C) Electron micrograph of lupus nep
n  mesangial area with some in subepithelial and subendothelial areas (ar
ntramembranous  electron dense deposits (arrow).
ith discrepancies from different regions of the world. King
bdulaziz  University and King Faisal Specialised Hospitals
re  two large tertiary medical centres in Western region
f  Saudi Arabia and are referral centres for LN. This study
epresents a large series of LN reported from Saudi Arabia.
urrently, there are no uniform national ﬁgures about data
able 6
requencies of therapeutics used.
Drug Patients given Patients not given
Hydroxychloroquine
(Plaquenil®)
96 (73.3%) 35 (26.7%)
Azathioprine  55 (44.7%) 68 (55.3%)
Cyclophosphamide 56 (46.7%) 64 (53.3%)
Pulse  steroid
prednisone
65  (53.3%) 57 (46.7%)
CellCept®
(mycophenolate
mofetil)
68  (55.7%) 54 (44.3%)
Methotrexate  11 (9.2%) 108 (90.8%)
Cyclosporine  23 (19.2%) 97 (80.8%)veals numerous discrete electron dense “immune-type” deposits mainly
) Electron micrograph of another case of lupus nephritis showing mainly
on LN from Saudi Arabia. Previously, the incidence of LN in
SLE  patients in Saudi Arabia had been reported from dif-
ferent  areas different occasions. In Riyadh region was 63%
in  1995 [13], 53.7% in 2007 [14], and 47.9% in 2009 [15]. In
Western  region was 55.4% [16], and 61% [17]. The present
study represent a cohort study from a subset of LN patients
in  Western Saudi Arabia attempting to provide data on the
prevalence, clinicopathological features, and therapy of LN
patients  and compare them to other studies both regionally
and  internationally.
In  this study, the median age and age range together
with sex predilection from this subset of cases are compara-
ble  with many international and national reports about LN
[16,18,19].  However, the median age is lower than reported
by  a study from central Asia [20], and also lower than a
large  study from the Eastern region of Saudi Arabia [15].
Also,  the female: male ratio was higher than previously
reported [15]. The reason of difference may  be referred
to difference ethnic distribution; as in our study the Saudi
population represents 65.5% patients while in their study
this  was  88.6%.
scopy an
[
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Although eclipse of 8 years since the introduction of
ISN/RPS classiﬁcation, we found that in these two centres
this  classiﬁcation is less frequently used and instead there
is  a heterogeneous mix  of WHO  classiﬁcations (1982 and
1995)  and sometimes ISN/RPS classiﬁcation were used. In
this  study, we re-classiﬁed this subset of cases according to
both  currently used classiﬁcations. The ﬁndings regarding
the  distribution of classes are similar to reports from differ-
ent  region continents. We  found that diffuse proliferative
LN (class IV) is the most frequent pathological lesion in
our  subset of cases. This ﬁnding is similar to previous
reports [5,15,18,19,21–25]. However, some studies from
Arab  countries showed higher incidence within class III
[26,27],  this difference from our ﬁnding is probably related
to  small sample size used in these studies or different eth-
nic  groups. Global lesions of class IV in the ISN/RPS 2003
classiﬁcation were higher than segmental lesions which
is  similar to ﬁndings of others [19,28]. Also the active
and chronic lesions were the highest (23.9%) among other
subcategories of IV-G which in concordance of Yokoyama
et  al. [19]. Results for activity and chronicity indices are
higher  than those reported by Hiramatsu et al. [29], the
cause  is that we used a larger sampler. In the meantime,
other studies were similar to ours [30] as this study used a
larger  sample. In the ISN/RPS 2003 classiﬁcation of LN the
description of classes III and IV depends on the reporting of
activity  and chronicity which depends on the proportion of
glomeruli  with active and chronic lesions.
In our study, we found a considerable number of cases
lacking the reporting of activity and chronicity features
in  original pathology reports and in cases that reported
pathologists were inconsistent. Some mentioned the ﬁnal
numerical  sum, in few cases the detailed items were
mentioned in microscopic description and ﬁnal diagno-
sis.  The microscopic description of each item of scoring
is  important to be reported because some active features
(subendothelial deposits or interstitial inﬂammation) are
therapeutically reversible while others like cellular cres-
cents  or necrosis are not [31]. IgG immunoﬂuorescence is
predominant among immunoglobulins which are associ-
ated  with early complements C1q, C4 as well as C3 similar
to  other reports [32].
In  our study, patients presenting with hypertension
constitutes 62.9%, which is higher than reported from pre-
viously  reported [15,25,30]. A small percentage of patients
were  diabetic which may  be related to steroid treatment.
Our results for ANA is similar to reported from other
national and regional studies [5,15]. While these results are
higher  than reported from a study from East Asia (78.4%)
[20].  This is referred to our large series of cases. The anti-
DNA  is higher than the range reported before [5,15,20].
Anti-cardiolipins were found elevated in a small percent-
age  (13.2% and 26.3%) which is far lower than the range
reported by Jallouli et al. [5] (71.6%) but comparable to
other  studies [27,33]. Levels of complements (C3 and C4)
were  low in 80.5% and 86.8% of tested patients. These ﬁg-
ures  are higher than other studies [5,15]. In a national
study, C3 was observed in low levels in half of cases which
was  associated with poor survival [15]. Proteinuria was
found  in 77.3% of cases which is higher than reported in
other  studies [15,18,24]. The mortality in this study is low
[
[d Ultrastructure 2 (2014) 12–19
and  is similar to previous ﬁnding from Western Saudi Ara-
bia  [16] and lower than from Eastern Saudi Arabia [15]. The
improved  survival rate in LN is attributed to early diagnosis,
improved patients response to treatment modalities.
The limitations of our study were unavailability of a
portion of clinical and pathological data including full sur-
vival  data, and lack of treatment outcome history.
5. Conclusion
We  have presented a series of LN in Western Saudi
Arabia and compared with results from other series.
Class IV was the most frequent type of nephritis seen
in  our patients. The usage of ISN/RPS in these two cen-
tres  is still limited. We  do encourage pathologists to use
the  activity and chronicity indices in details and to use
ISN/RPS classiﬁcation. There is still some discrepancies
regarding clinicolaboratory features of LN among national
and  regional areas. Continuous reporting from different
national specialised nephrology centres is recommended
for awareness of the magnitude of this disease in Saudi
Arabia.
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